September 13, 2019
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Healthcare & Insurance
100 F Street, N.E.
Washington, DC 20549
| Attention: | Justin Dobbie |
Julia Griffith
Sharon Blume
Christine Torney
| Re: | IGM Biosciences, Inc. |
Registration Statement on Form S-1 (File No. 333-233365)
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between September 3, 2019 and the date hereof, approximately 1,140 copies of the Preliminary Prospectus dated September 3, 2019 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Tuesday, September 17, 2019 or as soon thereafter as practicable.
[Signature page follows]
Very truly yours,
JEFFERIES LLC
PIPER JAFFRAY & CO.
STIFEL, NICOLAUS & COMPANY, INCORPORATED
As representatives of the Underwriters
| By: | Jefferies LLC |
| By: | /s/ Dustin Tyner | |||
| Name: | Dustin Tyner | |||
| Title: | Managing Director | |||
By: | Piper Jaffray & Co. |
By: | /s/ Chris Collins | |||
Name: | Chris Collins | |||
Title: | Managing Director | |||
By: | Stifel, Nicolaus & Company, Incorporated |
By: | /s/ Nathan Thompson | |||
Name: | Nathan Thompson | |||
Title: | Director | |||
[IGM Biosciences, Inc. – Signature Page to the Acceleration Request]
